Autopsy report · NCT01875198
Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
Cause of deathSlow enrollment
“because of difficulties of enrolling appropriate participants”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 1 year before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Yonsei University
- Sponsor type
- University, hospital or other
- Conditions
- Left-sided Pancreatic Cancer; Ductal Adenocarcinoma
- Interventions
- Radical Antegrade Modular Pancreatectomy with Splenectomy; Radical Antegrade Modular Pancreatectomy without splenectomy
- Participants
- 1
- Sites
- 1
- Countries
- South Korea
Trials that died the same way
- Safe and Effective Sedation in Chronic Alcoholic Patients Underwent Diagnostic Endoscopic Procedures: Study Comparing Midazolam and Propofol With Midazolam
“because of difficulties for participants enrollment” - Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
“Difficult to enroll participants” - Efficacy and Safety of Empagliflozin in NODAT
“Difficult in enrolling suitable participants” - Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
“due to the difficulty to enroll suitable patients” - Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project
“Severe difficulties in enrolling individuals”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.